• Development and characterisation of a panel of phosphatidylinositide 3-kinase - mammalian target of rapamycin inhibitor resistant lung cancer cell lines.

    Thumbnail Image

    Files

    s41598-018-19688-1.pdf (2.09 MB)

    Date

    2018

    Authors

    Journal Title

    Journal ISSN

    Volume Title

    Publisher

    Access

    openAccess

    Embargo end date

    Citation

    Heavey S, Dowling P, Moore G, Barr MP, Kelly N, Maher SG, Cuffe S, Finn SP, O'Byrne KJ, Gately K., Development and characterisation of a panel of phosphatidylinositide 3-kinase - mammalian target of rapamycin inhibitor resistant lung cancer cell lines., Scientific Reports, 8, 1, 2018, 1652-

    Abstract

    Description

    PUBLISHED

    URI

    http://hdl.handle.net/2262/82627

    Collections

    Clinical Medicine (Scholarly Publications)
    RSS Feeds

    Endorsement

    Review

    Supplemented By

    Referenced By

    Keywords

    Sponsor: Irish Cancer Society
    Grant Number: CRS11HEA

    Author's Homepage: http://people.tcd.ie/barrma

    Author: Barr, Martin

    Author: O'Byrne, Ken

    Author: Finn, Stephen

    Author: Gately, Kathy

    Author: Maher, Stephen

    Author: Cuffe, Sinead

    Type of material: Journal Article